Mitochondrial Disease | CHOP Research Institute

Mitochondrial Disease

Published on
Nov 9, 2022
A U.S. Department of Defense grant will support CHOP researchers in their study of noninvasive methods to diagnose mitochondrial diseases.
Published on
Oct 28, 2022
In the News: Researcher Awards, Hearing Loss in Mitochondrial Disease, Abu Dhabi Partnership

Evaluate the safety and efficacy of an investigational drug called "Elamipretide" in adult patients with mitochondrial disease.

Study focusing on non-invasive MRI procedures to measure biological activity within leg muscles of individuals, including both healthy volunteers and those with mitochondrial disease.

We are recruiting patients with genetically confirmed primary mitochondrial myopathy who are at least 18 years old for a randomized, double-blind, placebo-controlled study of a new drug to treat this disorder.

Published on
Sep 16, 2022
This week’s In the News highlights research on mitochondrial disease, acute lymphoblastic leukemia, type 2 diabetes, and sleep apnea.
Published on
Apr 29, 2022
Read about the latest discoveries and awards at Children’s Hospital of Philadelphia Research Institute.
Published on
Sep 22, 2021
Marni Falk, MD, and Adam Resnick, PhD, to lead the Mitochondria and Cancer Connections (MC²) Research Program, a new CHOP research initiative.
Published on
Sep 3, 2021
This week’s In the News highlights two new studies, a new grant, the new director of the Cystic Fibrosis Center, and a physician’s new role.

The purpose of this research study is to validate the use of surveys such as fatigue scales, Mitochondrial Disease scales, and quality of life scales.